Commerce Bank grew its holdings in Paragon 28, Inc. (NYSE:FNA – Free Report) by 28.5% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 18,350 shares of the company’s stock after purchasing an additional 4,075 shares during the period. Commerce Bank’s holdings in Paragon 28 were worth $123,000 as of its most recent SEC filing.
A number of other large investors also recently made changes to their positions in the business. GSA Capital Partners LLP acquired a new position in shares of Paragon 28 in the 3rd quarter valued at about $386,000. Park Edge Advisors LLC increased its holdings in shares of Paragon 28 by 2.7% in the 3rd quarter. Park Edge Advisors LLC now owns 598,870 shares of the company’s stock valued at $4,000,000 after purchasing an additional 15,727 shares during the period. Ballentine Partners LLC acquired a new position in shares of Paragon 28 in the 3rd quarter valued at about $91,000. Creative Planning acquired a new position in shares of Paragon 28 in the 3rd quarter valued at about $91,000. Finally, Inspire Investing LLC grew its stake in shares of Paragon 28 by 18.5% in the 3rd quarter. Inspire Investing LLC now owns 62,148 shares of the company’s stock valued at $415,000 after buying an additional 9,681 shares in the last quarter. Institutional investors and hedge funds own 63.57% of the company’s stock.
Insiders Place Their Bets
In other Paragon 28 news, major shareholder Mvm Partners, Llc sold 147,581 shares of the company’s stock in a transaction that occurred on Wednesday, November 20th. The stock was sold at an average price of $10.28, for a total transaction of $1,517,132.68. Following the completion of the sale, the insider now owns 10,738,564 shares of the company’s stock, valued at $110,392,437.92. This represents a 1.36 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Insiders sold 230,549 shares of company stock valued at $2,359,329 over the last 90 days. 15.32% of the stock is currently owned by company insiders.
Wall Street Analyst Weigh In
View Our Latest Analysis on Paragon 28
Paragon 28 Stock Up 0.1 %
Shares of Paragon 28 stock opened at $9.99 on Thursday. The stock has a market capitalization of $836.36 million, a P/E ratio of -13.50 and a beta of 1.01. The company has a quick ratio of 1.60, a current ratio of 3.50 and a debt-to-equity ratio of 0.79. The stock has a 50 day moving average price of $6.89 and a two-hundred day moving average price of $7.26. Paragon 28, Inc. has a 12-month low of $4.65 and a 12-month high of $14.79.
Paragon 28 (NYSE:FNA – Get Free Report) last announced its earnings results on Tuesday, November 12th. The company reported ($0.15) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.16) by $0.01. The firm had revenue of $62.30 million during the quarter, compared to analysts’ expectations of $60.58 million. Paragon 28 had a negative return on equity of 37.90% and a negative net margin of 25.31%. The company’s revenue was up 18.0% on a year-over-year basis. During the same quarter in the prior year, the business earned ($0.10) earnings per share. Equities analysts expect that Paragon 28, Inc. will post -0.66 earnings per share for the current year.
Paragon 28 Company Profile
Paragon 28, Inc develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems.
Read More
- Five stocks we like better than Paragon 28
- How to Use the MarketBeat Excel Dividend Calculator
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- What is the Euro STOXX 50 Index?
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- How to Calculate Retirement Income: MarketBeat’s Calculator
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Paragon 28 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Paragon 28 and related companies with MarketBeat.com's FREE daily email newsletter.